Los puntos clave no están disponibles para este artículo en este momento.
More than 10% of the general U.S. adult population have CRS symptoms. Most report severe symptoms, lack of satisfaction with current treatment options, and a substantial adverse impact on daily functioning.
Palmer et al. (Mon,) studied this question.